Bioceres Crop Solutions Corp., a global agricultural technology company focused on developing and commercializing innovative solutions that improve crop productivity while advancing regenerative agriculture, has announced its financial results for the third quarter of fiscal year 2026, covering the period ended March 31, 2026. The company, known for its work in crop resilience and climate-smart agriculture, reported a challenging quarter marked by softer market demand, strategic restructuring, and continued efforts to strengthen its financial position.
The latest quarterly report reflects a business undergoing significant transition as it seeks to sharpen its operational focus and reposition itself for long-term sustainable growth. Financial figures were reported in U.S. dollars and prepared according to International Financial Reporting Standards (IFRS), with all year-over-year comparisons measured against the same period last year.
Pro Farm Divestiture Alters Financial Presentation
A major factor influencing Bioceres’ reported results this quarter was the exclusion of its former Pro Farm Group (PFG) business from continuing operations. In January 2026, PFG underwent a foreclosure auction, prompting the company to classify the business as discontinued operations.
As a result, all continuing financial results now exclude Pro Farm, and prior-year numbers have been adjusted accordingly to ensure more accurate comparisons. This accounting adjustment significantly changes how investors interpret the company’s core operational performance, as the reported numbers now focus solely on Bioceres’ remaining businesses.
Revenue Declines as Crop Protection and Seeds Face Headwinds
Bioceres posted total third-quarter revenues of $39.4 million, representing a 23% decline year-over-year.
The company attributed this decrease primarily to weaker demand and competitive pricing pressures within its Crop Protection segment, which has faced slower purchasing patterns across several markets. Additionally, the company’s Seeds division continued its transition toward a more asset-light business model, reducing near-term revenue contributions while the restructuring takes place.
Despite these challenges, one business segment delivered a bright spot. Crop Nutrition revenues increased 15% year-over-year, supported largely by continued momentum in microbeaded fertilizers, a technology area that remains central to Bioceres’ long-term innovation strategy.
Management emphasized that the mixed segment performance reflects evolving market conditions rather than structural weakness across the broader business.
Gross Profit Pressured by Lower Volumes and Inventory Adjustments
Gross profit for the quarter came in at $12.7 million, with a gross margin of 32%.
This represented a decline from the previous year due to lower overall revenues and an unfavorable product mix across business units.
In addition, Crop Nutrition profitability was negatively affected by a non-recurring inventory obsolescence adjustment tied to inoculants. The company said this charge resulted from efforts to normalize inventory levels and improve balance sheet efficiency.
While management described the adjustment as temporary, it contributed to reduced margins during the quarter.
Cost Controls Deliver Operating Expense Improvements
One of the more encouraging developments in the quarter was Bioceres’ progress on cost discipline.
Selling, general, and administrative (SG&A) expenses declined 16% year-over-year, reflecting ongoing organizational streamlining and tighter spending controls.
The company has been actively implementing operational efficiency initiatives across its continuing businesses, including:
- reducing overhead costs,
- optimizing workforce structure,
- improving procurement efficiency,
- and enhancing working capital management.
Executives noted that these measures are beginning to generate tangible financial benefits and are expected to support profitability recovery over time.
Net Loss Widens as EBITDA Turns Negative
Bioceres reported a net loss of $10.0 million for the quarter.
Adjusted EBITDA came in at negative $0.6 million, reflecting weaker gross profit and the absence of prior-year non-cash gains.
In the comparable quarter last year, results benefited from one-time accounting income related to the reorganization of the Seeds business, including contractual and intellectual property adjustments. Since that benefit did not recur this year, year-over-year profitability comparisons appear more severe.
Management stressed that this accounting difference should be considered when evaluating operational performance.
Liability Management Becomes a Strategic Priority
Beyond operational performance, Bioceres continues addressing balance sheet pressures.
Following the Pro Farm foreclosure and related disputes with noteholders, the company has intensified its liability management initiatives.
These efforts include:
- debt reprofiling across operating subsidiaries,
- extending debt maturities,
- and managing obligations tied to bondholders in Argentina.
Executives indicated that preserving liquidity and strengthening financial flexibility remain key priorities during this transition period.
CEO Highlights “Transition and Refocusing”
Chief Executive Officer Federico Trucco described the quarter as one of “transition and operational refocusing.”
According to Trucco, the company is concentrating on strengthening internal fundamentals while preparing for future growth.
“This quarter reflects a period of transition and operational refocusing for the company,” he said. “While market conditions remain challenging in several areas and the effects of the Seeds transition continue to impact reported results, we are increasingly focused on strengthening the fundamentals of the organization and prioritizing disciplined execution.”
He emphasized that Bioceres is actively:
- simplifying its corporate structure,
- improving operational efficiency,
- enhancing cash generation,
- and reinforcing governance processes.
A broader strategic review is also underway, examining how best to allocate capital and management attention toward the company’s highest-value opportunities.
Strategic Review Could Shape Future Portfolio Decisions
Management confirmed it is conducting a review of continuing operations to determine where the company can create the most long-term value.
This process could lead to additional restructuring, portfolio optimization, or changes in investment priorities.
The review is expected to focus heavily on businesses aligned with Bioceres’ core strengths:
- biological crop inputs,
- climate-resilient seeds,
- and regenerative agricultural technologies.
Industry analysts note that such a review may ultimately streamline the company into a more focused ag-biotech platform.
Pro Farm Litigation Adds Uncertainty
Executives also acknowledged the uncertainty created by the Pro Farm foreclosure and ongoing legal proceedings.
While Bioceres continues to pursue legal remedies and alternative solutions, leadership said its immediate focus is stabilizing core operations and protecting shareholder value.
“We recognize the significance of the events surrounding Pro Farm and the uncertainty generated by the litigation process,” Trucco stated. “Our priority remains clear: stabilizing the business, preserving the value of our core operations, and positioning the company for a more resilient and sustainable future.”
Crop Nutrition Remains a Growth Engine
Despite broader challenges, Crop Nutrition continues to demonstrate resilience.
Demand for microbeaded fertilizers remained strong during the quarter, reinforcing management’s belief that biological and efficiency-enhancing agricultural inputs represent a major future growth opportunity.
As farmers worldwide increasingly seek tools to improve yields while reducing environmental impact, Bioceres believes this business segment could become an increasingly important earnings contributor.
Source Link:https://www.businesswire.com/
